The U.S. missed President Biden’s big vaccination goal: 70% of adults vaccinated with at least one dose by July 4. As of July 3, we are at 67% of adults with one dose, and 58% fully vaccinated.
I did a data-driven look at the vaccination goal this week in a story for the Daily Mail. The story focuses on which parts of the country have met the goal—and which areas fell short. Those under-vaccinated areas are highly vulnerable to the Delta variant (B.1.617.2), which is now spreading rapidly in many of those pockets. Reminder: the Delta variant is much more transmissible than even the Alpha variant (B.1.1.7), and its presence is doubling in the U.S. every two weeks.
There are over 1,000 counties in the U.S. with one-dose vaccination rates under 30%, CDC Director Dr. Walensky said at a press briefing last week. The U.S. has about 3,100 counties in total.
Is your county one of them? Check it out on this interactive map, reflecting data as of July 1:
I also made a map showing vaccination rates by metropolitan area. You can clearly see clusters of high vaccination in the Northeast and on the West coast, while parts of the South and Midwest are under-vaccinated. Note that Texas is missing in both this dataset and the county-level data due to issues in the state’s reporting to the CDC.
For my Daily Mail story, I also asked two of the COVID-19 science communicators I most admire to explain the significance of that missed 70% goal. I talked to Dr. Uché Blackstock, physician and founder of the organization Advancing Health Equity, and Dr. Katelyn Jetelina, epidemiologist at the University of Texas and writer of the Your Local Epidemiologist newsletter.
Here are both of their takes on the missed goal:
So, we didn’t meet the 70% goal. It means that we fell short. It also means that we just don’t have enough people vaccinated, not even close, to reach herd immunity.
To me, as an epidemiologist, someone in the field and also someone within a community, it means that we have reached—or are about to reach—saturation [of the vaccine market]. We need to start becoming very innovative about how to address vaccine hesitancy, as well as how to address vaccine equity.
That’s really going to be the next phase of public health approaches. And then, how do we go about doing this… You know, we’re well beyond billboards now. We really need to mobilize a grassroots movement. We need to listen about concerns, we need to educate about these concerns.
And then, we need to make vaccines more accessible. Especially among pediatrics, where—pediatrician offices can’t store the vaccine. So we have to go to schools and really engage with families in a “nontraditional sense.”Dr. Katelyn Jetelina
This 70%, especially for one dose, is sort of an arbitrary number, because we know that being fully vaccinated is what’s needed to fully protect you against variants. I think it was obviously wise and aspirational to have a goal. But at this point, because we’re basically seeing the number of people vaccinated decreasing weekly, and substantially since last April… I think we need to change our perspective.
We had the early adopters who came in droves to get vaccinated. We’re not going to see the same numbers anytime soon. And so, I think that this idea of having a goal, while it’s aspirational, I think that we have to put that aside and think more realistically about the challenges we’re dealing with.
And the challenges we’re dealing with are actually quite complicated… There are still access issues, although I do think the Biden administration is doing—at least trying to do a substantial job in knocking down those barriers. They’re providing transportation, childcare, increasing the access points for getting vaccinations, encouraging small businesses to offer their workers paid sick leave to get vaccinated and to recover from the vaccine.
But I think this other issue that we’re seeing among people who are not vaccinated, it varies depending on the population, the geographical area. We know rural populations are less likely [to get vaccinated]. And we know that, among the “wait and see” group, about half of those are people of color.
I hate to blame it on this so-called “vaccine hesitancy” because I don’t think it’s that simple. I do think, though, that there is a significant distrust of government, there is distrust of the healthcare system, and there is a lot of misinformation out there about the vaccines. All of these are essentially creating the perfect storm that is preventing us from getting to this aspirational [70%] number.
But here, we’re at this point where it’s a race against the variants, and I think that we just have to get as many people vaccinated as possible. I know that sounds incredibly vague, but that really is the goal.Dr. Uché Blackstock
I made a third chart for today’s issue, visualizing vaccination rates by state from March through June. It really shows how vaccine enthusiasm has leveled off, just about everywhere in the country—but the plateaus started earlier in many of those states that have lower rates now.
I typically try to avoid anything approaching medical advice in the COVID-19 Data Dispatch, as I am a journalist with just an undergraduate biology degree and a couple of years of science reporting experience. But this week, it feels appropriate to wholeheartedly, unambiguously encourage vaccination.
I know the audience for a publication like this one skews towards people who probably have their shots already. Rather, I want to encourage you to find those people in your community who aren’t yet vaccinated, and help them take that step.
Recent research suggests that lotteries and other large-scale incentives do not significantly encourage vaccination; instead, we need small-scale incentives. One-on-one conversations with people, opportunities for concerns to be voiced and addressed, appointments that can be tailored to the individual’s needs. Anything that you can do to play a role in these initiatives, please get out there and do it.
Of course, if you (or your friends/family/community members/etc.!) have questions about vaccines, or anything else COVID-19 related, you know where to find me. Inquiries welcome at email@example.com.
More vaccine reporting
- The booster shot conversation: What you should knowRecently, a lot of U.S. COVID-19 news has centered around booster shots—additional vaccine doses to boost patients’ immunity against the coronavirus. Questions abound: do we need these shots, when might we need them, how do they impact vaccination campaigns?
- What’s up with Texas’ county-level vaccination data?Anyone who’s tried to work with the federal government’s vaccination data has noticed this issue: there’s a Texas-shaped hole in the numbers. While the CDC and HHS report vaccination data for counties and metropolitan areas in the vast majority of states, data are missing for the entire state of Texas.
- Breakthrough cases: What we know right nowWhile epidemiologists may consider any new outbreak a possible source of new variants, one key way to monitor the virus/variant race is by analyzing breakthrough cases—those infections that occur after someone has been fully vaccinated. Here’s how states and the CDC are tracking these cases now, and what we know about vaccine protection against the variants.
- The US missed Biden’s July 4 goal: How did your community do?The U.S. missed President Biden’s big vaccination goal: 70% of adults vaccinated with at least one dose by July 4. As of July 3, we are at 67% of adults with one dose, and 58% fully vaccinated. But rates vary widely by state and county: There are over 1,000 counties in the U.S. with one-dose vaccination rates under 30%, CDC Director Dr. Walensky said at a press briefing last week.
- Novavax vaccine performs well—including against variantsThe COVID-19 news world saw a return of Monday-morning vaccine results this week. Novavax, a small biotech company based in Maryland, announced that its vaccine demonstrated 90% overall efficacy and 100% protection against moderate and severe COVID-19 disease.